Bausch + Lomb BLCO Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Pharmaceuticals | $300M+15.4% | $266M+19.8% | $319M+19.0% | $280M+13.4% | $260M+6.1% | |
| Surgical | $256M+18.5% | $228M+6.5% | $249M+7.8% | $215M+4.4% | $216M+3.3% | |
| Vision Care | $784M+4.1% | $711M+8.4% | $778M+7.6% | $736M+7.6% | $753M+8.0% | |
| Total revenues by Product | ||||||
| Branded and Other Generics | $68M+17.2% | $49M-9.3% | $71M+2.9% | $59M-15.7% | $58M-23.7% | |
| Devices | $524M+11.0% | $480M+7.1% | $518M+8.8% | $484M+6.4% | $472M+6.1% | |
| OTC | $497M+3.1% | $444M+8.6% | $490M+6.1% | $454M+8.1% | $482M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch + Lomb break its business down?
- Bausch + Lomb (BLCO) reports total revenues by business across 3 parts — Pharmaceuticals, Surgical and Vision Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch + Lomb's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch + Lomb's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
